Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UROFOLLITROPIN vs USTEKINUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UROFOLLITROPIN vs USTEKINUMAB: Safety Overview

Metric UROFOLLITROPIN USTEKINUMAB
Total FAERS Reports 101 85,332
Deaths Reported 1 4,519
Death Rate 1.0% 5.3%
Hospitalizations 84 17,127
Average Patient Age 32.6 yrs 48.1 yrs
% Female Patients 97.6% 60.3%
Manufacturer N/A SANDOZ INC
Route N/A SUBCUTANEOUS
Marketing Status Discontinued Prescription